Detalhe da pesquisa
1.
The life history of 21 breast cancers.
Cell;
149(5): 994-1007, 2012 May 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22608083
2.
Mutational processes molding the genomes of 21 breast cancers.
Cell;
149(5): 979-93, 2012 May 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22608084
3.
The landscape of cancer genes and mutational processes in breast cancer.
Nature;
486(7403): 400-4, 2012 May 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22722201
4.
Breast-cancer risk in families with mutations in PALB2.
N Engl J Med;
371(6): 497-506, 2014 Aug 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25099575
5.
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.
Carcinogenesis;
35(5): 1012-9, 2014 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24325915
6.
Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
Breast Cancer Res Treat;
139(1): 193-8, 2013 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23580068
7.
Isolation of Genomic DNA from Mammalian Cells and Fixed Tissue.
Curr Protoc;
3(7): e818, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37399289
8.
Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patients.
PLoS One;
15(3): e0230529, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32163513
9.
Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients.
PLoS One;
14(5): e0216997, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31125336
10.
Somatic T-cell Receptor Diversity in a Chronic Kidney Disease PatientPopulation Linked to Electronic Health Records.
AMIA Jt Summits Transl Sci Proc;
2017: 63-71, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29888042
11.
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
J Clin Oncol;
33(4): 304-11, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25452441
12.
NF-κB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growth.
Mol Cancer Res;
12(3): 408-420, 2014 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24319068
13.
Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
Nat Genet;
45(4): 392-8, 398e1-2, 2013 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23535733
14.
BRCA1-IRIS overexpression promotes formation of aggressive breast cancers.
PLoS One;
7(4): e34102, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22511931
15.
19p13.1 is a triple-negative-specific breast cancer susceptibility locus.
Cancer Res;
72(7): 1795-803, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22331459
16.
PALB2 mutations in familial breast and pancreatic cancer.
Fam Cancer;
10(2): 225-31, 2011 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21365267
17.
Common breast cancer susceptibility loci are associated with triple-negative breast cancer.
Cancer Res;
71(19): 6240-9, 2011 Oct 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21844186
18.
Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter.
J Biol Chem;
283(44): 29671-80, 2008 Oct 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18765668
19.
Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
J Surg Res;
138(1): 37-44, 2007 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17109887
20.
Serial transplantation of NMU-induced rat mammary tumors: a model of human breast cancer progression.
Int J Cancer;
121(3): 474-85, 2007 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17405122